Dolutegravir Pharmacokinetics Differ Between Pregnant and Postpartum Women Dolutegravir Pharmacokinetics Differ Between Pregnant and Postpartum Women

The pharmacokinetics of dolutegravir, used to treat HIV infection, differ between pregnant women and postpartum women, but the differences are not likely to impair the drug ' s efficacy or safety.Reuters Health Information
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: Ob/Gyn & Women ' s Health News Source Type: news